Skip to content

Launch of the ADD4KIDS European Action Plan to Fast-Track Paediatric Innovation

The ADD4KIDS project launches the "European Action Plan for Paediatric Innovation" that outlines a coordinated strategy to accelerate the adoption of health solutions for children. It also promotes cross-border collaboration and innovative financing to address long-standing barriers. The Plan calls on all stakeholders to help bring impactful paediatric innovations to patients faster.
ADD4KIDS European Action Plan

The ADD4KIDS project officially presented the “European Action Plan for Paediatric Innovation”, a strategic framework aimed at bridging the gap between technological development and practical implementation in paediatric healthcare.

Developed by EIT Health in collaboration with ADD4KIDS partners, including i4KIDS, the Action Plan outlines structured, cross-border strategies to facilitate the adoption of innovative healthcare solutions for children across Europe.

Advancing Paediatric Healthcare Through Strategic Coordination

While significant progress has been made in health technology, the paediatric field continues to encounter structural challenges that hinder the adoption of innovation. These include market fragmentation, limited regulatory alignment, and a lack of demand-driven investment approaches.

The Action Plan proposes solutions by promoting the use of targeted financing instruments such as:

  • Pre-Commercial Procurement (PCP)
  • Public Procurement of Innovation (PPI)
  • Value-Based Procurement (VBP)
  • Social Impact Bonds (SIBs)

These tools are designed to reduce market barriers, align incentives among stakeholders, and support the sustainable integration of innovation into clinical practice.

ThisEuropean Action Plan for Paediatric Innovation” aims to mobilise all actors involved in healthcare innovation to take an active role in transforming the paediatric landscape in Europe.

From healthcare professionals and public institutions to startups, investors, and industry representatives—this is an open invitation to:

  • Engage in cross-border initiatives

  • Implement innovative funding mechanisms

  • Accelerate the delivery of effective paediatric solutions to children in need

i4KIDS’ Contribution to the Action Plan

As a member of the ADD4KIDS consortium, i4KIDS, coordinated by SJD Barcelona Children’s Hospital, has contributed its expertise in innovation ecosystems, clinical validation, and translational strategy to the development of the Action Plan.

i4KIDS continues to support the implementation of demand-driven models that enhance collaboration between healthcare providers, technology developers, and policymakers to improve access to paediatric innovations.

Engaging Stakeholders Across the Ecosystem

The publication of the Action Plan marks an important step toward fostering a more coordinated and efficient paediatric innovation landscape. It serves as a reference for organisations involved in research, development, and procurement of paediatric health solutions.

📄 Access the full European Action Plan here

Organisations working on related initiatives or interested in contributing to the Action Plan’s objectives are encouraged to explore potential synergies with ADD4KIDS partners: Institut de Recerca Sant Joan de Déu – Fundació Sant Joan de Déu (FSJD-CERCA) , Barcelona Children’s Hospital Sant Joan de Déu HSJD, EIT Health (Institute of Innovation and Technology), Inveniam Group, SCIENSANO, The Children’s Memorial Health Institute, Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) and The European Children’s Hospitals Organisation (ECHO).

 

About the author
i4KIDS
Content by i4KIDS
Related News
i4KIDS Training Capsule

Uncategorized

i4KIDS and Catalonia.Health brought together startup leaders, researchers and healthcare professionals to discuss funding, regulatory strategy and international growth. The session featured Gisela Lorente (Aptadel Therapeutics), Marc Martinell (Minoryx Therapeutics) and Stefanos Theoharis (OneChain Immunotherapeutics), highlighting Barcelona's growing role as a leading hub for paediatric health innovation.
CogniTOT

Uncategorized

The European project i4KIDS-4RARE has selected CogniTOT, a language-independent digital cognitive assessment tool developed by Liltoda Ltd, as the winning solution of its Neuroepilepsy Innovation Programme. Validated in more than 1,000 children across ten countries, the tool will now enter a pilot phase within the EpiCARE network to assess its potential for the early detection and monitoring of cognitive impairment in children living with rare epilepsies.

Uncategorized

The i4KIDS Acceleration Programme 2026 has officially launched its new cohort, bringing together five high-potential projects that showcase the diversity and strength of paediatric innovation. From breakthrough therapies for rare diseases and childhood cancer to advanced medical technologies and digital solutions tailored for paediatric care, the selected initiatives address pressing unmet clinical needs. Through a structured training and mentoring pathway, the programme will support teams in advancing clinical validation, regulatory readiness, technology transfer and market access, with a strong focus on delivering sustainable solutions and tangible impact for children and families.